The results demonstrated that colchicine was associated with a significant reduction in hs-CRP and IL-6 levels, as well as a lower incidence of adverse cardiovascular events, particularly myocardial infarction and recurrent myocardial ischemia. The gene discussed is IL6; the disease is myocardial infarction.